Third Rock Ventures V, L.P. - Dec 31, 2024 SCHEDULE 13G Report for Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share (RAPP)

Filing Manager
Third Rock Ventures V, L.P.
Reporting Manager
Third Rock Ventures V, L.P.
Security
Rapport Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
RAPP
Shares outstanding
36.6M shares
Disclosed Ownership
7.14M shares
Ownership
19.5%
Form type
SCHEDULE 13G
Date filed
2/13/2025, 04:15 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Third Rock Ventures V, L.P. 19.5% 7.14M 0 7.14M /s/ Kevin Gillis Kevin Gillis, COO of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
Third Rock Ventures GP V, L.P. 19.5% 7.14M 0 7.14M /s/ Kevin Gillis Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P
TRV GP V, LLC 19.5% 7.14M 0 7.14M /s/ Kevin Gillis Kevin Gillis, Chief Operating Officer of TRV GP V, LLC
Third Rock Ventures VI, L.P. 2.7% 969K 0 969K /s/ Kevin Gillis Kevin Gillis, COO of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P., general partner of Third Rock Ventures VI, L.P.
Third Rock Ventures GP VI, L.P. 2.7% 969K 0 969K /s/ Kevin Gillis Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC, general partner of Third Rock Ventures GP VI, L.P.
TRV GP VI, LLC 2.7% 969K 0 969K /s/ Kevin Gillis Kevin Gillis, Chief Operating Officer of TRV GP VI, LLC